CORONAVIRUS/Taiwan's COVID vaccines about to enter phase 2 clinical trials: FDA

12/23/2020 09:16 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Dec. 23 (CNA) A number of COVID-19 vaccines developed in Taiwan have completed the first phase of clinical trials and are likely to enter phase 2 trials by the end of the year, the nation's Food and Drug Administration (FDA) said Wednesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.